CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Brief Summary:The FREEDOM study aims to develop a scalable intervention to improve type 2 diabetes mellitus control in low-income Black adul...
Birmingham, Alabama, United States
This study is designed to evaluate the safety and effectiveness of endoscopic intestinal re-cellularization therapy in individuals with type 2 diabetes...
Birmingham, Alabama, United States and 45 other locations
Objectives The objective of this clinical trial is to assess whether ladarixin treatment has an effect to preserve β-cell function and delay the prog...
Phase 2
Birmingham, Alabama, United States and 56 other locations
placebo-controlled, multicenter to evaluate the efficacy, safety, and tolerability of AZD6234 in adults with overweight or obesity and type 2 diabetes...
Phase 2
Birmingham, Alabama, United States and 13 other locations
This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing ...
Phase 4
Birmingham, Alabama, United States and 89 other locations
The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...
Phase 3
Birmingham, Alabama, United States and 654 other locations
The purpose of this study is to find out how well a new continuous glucose monitor works for people with diabetes. This study will test the ....
Birmingham, Alabama, United States and 27 other locations
double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes...
Phase 2
Vestavia Hills, Alabama, United States and 119 other locations
weight in adult participants with obesity or overweight and type 2 diabetes. The study will last about 77 weeks and may include up to 22 vis...
Phase 3
Pelham, Alabama, United States and 138 other locations
This study will evaluate the safety and efficacy of ertugliflozin (MK-8835) in pediatric participants with T2DM on metformin with/without insulin. Th...
Phase 3
Birmingham, Alabama, United States and 103 other locations
Clinical trials
Research sites
Resources
Legal